Drug intelligence / Profile preview

β-glucan nanoparticles

Development stage
Preclinical
Modality
Nanoparticles → Drug Delivery Systems
Administration
Intravenous, Oral, Rectal
01

Overview

β-Glucan nanoparticles are advanced drug delivery systems based on the polysaccharide β-glucan, which is naturally found in the cell walls of fungi and yeasts. These particles are engineered to encapsulate or bind therapeutic agents such as small molecules (e.g., anticancer drugs), proteins, nucleic acids (DNA/RNAi), or other nanomaterials (e.g., magnetic iron oxide or gold nanoparticles). The primary mechanism of action involves targeted delivery to phagocytic immune cells—especially macrophages—via specific receptors like Dectin-1 and complement receptor 3 (CR3) that recognize β-glucans. This enables selective uptake by immune cells and can enhance immunomodulation and antitumor responses[2][4][6].

Other names
beta-glucan nanoparticlesbeta-1,3 glucan nanoparticlesβ-1,3 glucan nanoparticles
02

Targets

αMβ2 (Integrin αMβ2)CLEC7A (Dectin-1)

Beyond the preview

Go deeper on β-glucan nanoparticles.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on β-glucan nanoparticles.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call